Agreement Establishes Anterix as an NRTC Resource in Making Anterix's 900 MHz Spectrum and Solutions Platform Available to its 1,500 Rural Utility Cooperative Members WOODLAND PARK, N.J., Aug. 6, 2024 /PRNewswire/ -- Anterix (NASDAQ: ATEX) announced today that it has been selected as a solutions provider by NRTC, which represents more than 1,500 rural electric and telephone utilities and affiliates in 48 states, collectively serving approximately 20 million homes and 48 million residents. Under the agreemen ...

文章核心观点 - 公司宣布收购UNLESS COLLECTIVE,INC,并任命Eric Liedtke为Under Armour执行副总裁,负责品牌战略 [1][2][4][5] - Eric Liedtke此前在adidas集团任职26年,担任过品牌总裁和执行董事会成员,在公司实现了超过80亿美元的收入增长 [3][7] - UNLESS COLLECTIVE是一家零塑料再生时尚品牌,致力于用植物材料取代塑料制造服装和鞋类产品 [8][9] 根据目录分类总结 Eric Liedtke背景 - Eric Liedtke在adidas集团任职26年,担任过多个高级职位,包括品牌营销副总裁、体育品牌营销高级副总裁和体育品牌负责人,最后担任品牌总裁和执行董事会成员 [7] - 在担任品牌总裁期间,他制定并实施了一项五年战略计划,帮助adidas实现了超过80亿美元的收入增长,推动了该公司在材料、创新、可持续性和街头时尚方面的突破 [7] - Liedtke拥有威斯康星大学麦迪逊分校的文学学士学位,是一名狂热的冲浪者、户外运动爱好者和健身爱好者 [7] Under Armour收购UNLESS COLLECTIVE - Under Armour宣布收购UNLESS COLLECTIVE,这是一家全植物、零塑料再生时尚品牌 [8][9] - UNLESS COLLECTIVE由创新者、工程师、艺术家和活动家组成的集体,致力于建立第一个再生时尚平台,连接材料、设计、制造和堆肥,利用植物创新和生产智慧来解决无塑料未来 [8][9] - Under Armour表示,收购UNLESS COLLECTIVE并任命Eric Liedtke为执行副总裁,将有助于提升Under Armour的品牌形象,增强消费者忠诚度,并推动公司长期增长 [4][5][6]

Real-world data confirms utility of EsoGuard as a non-invasive triage tool to significantly increase positive yield of invasive upper endoscopy NEW YORK, Aug. 6, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the release of new real-world data from its ENVET-BE study supporting the clinical utility of the EsoGuard® Esophageal DNA test  as a ...

HORSHAM, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that Dr. Dolev Rafaeli, President and Chief Executive Officer, and Christopher Lesovitz, Chief Financial Officer, will participate in the 9th Annual Virtual Needham MedTech & Diagnostics 1x1 Conference being held on August 12 – 13, 2 ...

- Announced positive outcomes from the C-GUARDIANS IDE clinical trial of the CGuard™ Prime carotid stent system demonstrating a one-year primary endpoint event rate of 1.95%, the lowest for any carotid stent or embolic protection device pivotal trial – - On track to submit a Premarket Approval (PMA) application to the FDA this quarter - - Raised gross proceeds of $17.9 million from full exercise of Series H warrants triggered by announcement of C-GUARDIANS data - --Management to host investor conference cal ...

201 Blocks Won in July, 27% Increase M/M BTC Production of 692 BTC, 17% Increase M/M Increased BTC Holdings to 20,818 BTC; Total Cash and BTC of $1.6B as of July 31, 2024 Fort Lauderdale, FL, Aug. 06, 2024 (GLOBE NEWSWIRE) -- MARA (NASDAQ: MARA) ("MARA" or the "Company"), one of the world's largest publicly traded bitcoin ("BTC") miners and a leader in supporting and securing the Bitcoin ecosystem, today published unaudited BTC production and miner installation updates for July 2024. Management Commentary " ...

DALLAS, Aug. 6, 2024 /PRNewswire/ -- Oncor Electric Delivery Company LLC ("Oncor") today reported three months ended June 30, 2024 net income of $251 million compared to three months ended June 30, 2023 net income of $200 million. The $51 million increase was driven by higher revenues primarily due to updated interim rates to reflect increases in invested capital, increases in transmission billing units, higher customer consumption primarily attributable to weather, the new base rates implemented in May 202 ...

文章核心观点 - 公司与大众汽车金融服务公司(VWFS)建立合作关系,利用数据和人工智能技术提升客户和员工体验,优化流程,增强行业竞争力[2][3][4][5] - 公司将在VWFS的业务中部署多种人工智能解决方案,包括提高客户服务和运营效率的工具[4][6] - 这些解决方案将提升员工绩效,缩短文书处理时间,主动满足客户需求,改善VWFS的整体客户体验[6] 行业总结 - 汽车金融行业面临着不断变化的客户期望、运营障碍和监管复杂性的挑战[5] - 公司利用数据、技术和人工智能的力量,为VWFS提供优化运营、提高客户满意度、降低风险和确保合规性的解决方案,最终推动VWFS的业务增长[5][6] 公司总结 - 公司拥有125,000多名员工,遍布30多个国家,致力于为客户创造持久价值[7] - 公司专注于数据、技术和人工智能,为金融服务行业提供深厚的行业知识和专业服务[5][7]

Collaboration to Leverage ImmunoForge's ELP Platform Technology Which Can Increase the Half-Life of a Drug by up to 200 Times CAMBRIDGE, Mass., Aug. 6, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it has signed a joint research agreement, together with Dong-A ST Co. Ltd. and ImmunoForge, to develop a long-acting, once-monthly, formulation of DA-1726, a novel, dual oxyntomoduli ...

Patient enrollment has accelerated, now with 13 patients enrolled in trial TFF TAC at ~20% of the oral tacrolimus dose prevented acute rejection and achieved >80% of the previous oral trough blood levels -- leading to diminished drug burden 9 out of 9 (100%) patients who completed the 12-week treatment chose to remain on TFF TAC by proceeding to the long-term extension Phase; 2 patients have been treated for over a year and 6 patients have been treated for more than 6 months Observed a 6.5-fold reduction in ...